Available Technologies
# of Displayed Technologies: 2 / 2
Applied Category Filter (Click To Remove): Medical Devices
Sustained Release Microparticles for the Treatment of Ocular Diseases
TS-038312 — A novel, intravitreal microparticle injection capable of controlled-release of protein therapies (including anti-VEGF) for tunable periods of 6-12 months after injection for the treatment of age-related macular degeneration.
Age-related macular degeneration (AMD) is the leading cause of blindness in individuals 65 and older and is the third leading cause of blindness worldwide. Wet AMD is characterized by abnormal growth of leaky blood vessels leading to damage to the macula of the retina resulting in vision loss and …
- College: College of Engineering (COE)
- Inventors: Jiang, Pengfei; Ohr, Matthew; Reilly, Katelyn
- Licensing Officer: Schworer, Adam
Oxygen Sensing Nanofibers
TS-014967 — Nanofibers designed to quantify the oxygen content of a local environment for cell cultures and tissue-based applications such as a wearable technology wirelessly integrated into an electronic device used to estimate the efficiency of an individual's oxygen consumption.
Measurements of growth and activity of living cells are advantageous in a wide array of applications. Such measurements can be used to track tissue regeneration, phenotypic change, localized hypoxia, the testing and development of antibiotics and much more (Maria Strianese et al., Scott Lynn et al…
- College: College of Engineering (COE)
- Inventors: Lannutti, John; Xue, Ruipeng
- Licensing Officer: Zinn, Ryan
